Source: Endocrinology. Unidade: ICB
Assunto: FISIOLOGIA
ABNT
CAPERUTO, Luciana Chagas et al. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology, v. 149, n. 12, p. 6326-6335, 2008Tradução . . Acesso em: 08 out. 2024.APA
Caperuto, L. C., Anhê, G. F., Cambiaghi, T. D., Akamine, E. H., Buonfiglio, D. do C., Cipolla Neto, J., et al. (2008). Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology, 149( 12), 6326-6335.NLM
Caperuto LC, Anhê GF, Cambiaghi TD, Akamine EH, Buonfiglio D do C, Cipolla Neto J, Curi R, Bordin S. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology. 2008 ; 149( 12): 6326-6335.[citado 2024 out. 08 ]Vancouver
Caperuto LC, Anhê GF, Cambiaghi TD, Akamine EH, Buonfiglio D do C, Cipolla Neto J, Curi R, Bordin S. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology. 2008 ; 149( 12): 6326-6335.[citado 2024 out. 08 ]